Patrice Quintana1,2, David Soto3, Olivier Poirot4,5,2, Marzieh Zonouzi3, Stephan Kellenberger5, Dominique Muller1, Roman Chrast2, Stuart G Cull-Candy3. 1. Department of Basic Neurosciences, University of Geneva, 1211 Geneva 4, Switzerland. 2. Department of Medical Genetics, University of Lausanne, 1005, Lausanne, Switzerland. 3. Department of Neuroscience, Physiology and Pharmacology, University College London, Gower Street, London, WC1E 6BT, UK. 4. Molecular Nociception Group, Wolfson Institute for Biomedical Research, University College London, London, WC1E 6BT, UK. 5. Department of Pharmacology and Toxicology, University of Lausanne, 1005, Lausanne, Switzerland.
Abstract
KEY POINTS: The hippocampal CA1 region is highly vulnerable to ischaemic stroke. Two forms of AMPA receptor (AMPAR) plasticity - an anoxic form of long-term potentiation and a delayed increase in Ca(2+) -permeable (CP) AMPARs - contribute to this susceptibility by increasing excitotoxicity. In CA1, the acid-sensing ion channel 1a (ASIC1a) is known to facilitate LTP and contribute to ischaemic acidotoxicity. We have examined the role of ASIC1a in AMPAR ischaemic plasticity in organotypic hippocampal slice cultures exposed to oxygen glucose deprivation (a model of ischaemic stroke), and in hippocampal pyramidal neuron cultures exposed to acidosis. We find that ASIC1a activation promotes both forms of AMPAR plasticity and that neuroprotection, by inhibiting ASIC1a, circumvents any further benefit of blocking CP-AMPARs. Our observations establish a new interaction between acidotoxicity and excitotoxicity, and provide insight into the role of ASIC1a and CP-AMPARs in neurodegeneration. Specifically, we propose that ASIC1a activation drives certain post-ischaemic forms of CP-AMPAR plasticity. ABSTRACT: The CA1 region of the hippocampus is particularly vulnerable to ischaemic damage. While NMDA receptors play a major role in excitotoxicity, it is thought to be exacerbated in this region by two forms of post-ischaemic AMPA receptor (AMPAR) plasticity - namely, anoxic long-term potentiation (a-LTP), and a delayed increase in the prevalence of Ca(2+) -permeable GluA2-lacking AMPARs (CP-AMPARs). The acid-sensing ion channel 1a (ASIC1a), which is expressed in CA1 pyramidal neurons, is also known to contribute to post-ischaemic neuronal death and to physiologically induced LTP. This raises the question does ASIC1a activation drive the post-ischaemic forms of AMPAR plasticity in CA1 pyramidal neurons? We have tested this by examining organotypic hippocampal slice cultures (OHSCs) exposed to oxygen glucose deprivation (OGD), and dissociated cultures of hippocampal pyramidal neurons (HPNs) exposed to low pH (acidosis). We find that both a-LTP and the delayed increase in the prevalence of CP-AMPARs are dependent on ASIC1a activation during ischaemia. Indeed, acidosis alone is sufficient to induce the increase in CP-AMPARs. We also find that inhibition of ASIC1a channels circumvents any potential neuroprotective benefit arising from block of CP-AMPARs. By demonstrating that ASIC1a activation contributes to post-ischaemic AMPAR plasticity, our results identify a functional interaction between acidotoxicity and excitotoxicity in hippocampal CA1 cells, and provide insight into the role of ASIC1a and CP-AMPARs as potential drug targets for neuroprotection. We thus propose that ASIC1a activation can drive certain forms of CP-AMPAR plasticity, and that inhibiting ASIC1a affords neuroprotection.
KEY POINTS: The hippocampal CA1 region is highly vulnerable to ischaemic stroke. Two forms of AMPA receptor (AMPAR) plasticity - an anoxic form of long-term potentiation and a delayed increase in Ca(2+) -permeable (CP) AMPARs - contribute to this susceptibility by increasing excitotoxicity. In CA1, the acid-sensing ion channel 1a (ASIC1a) is known to facilitate LTP and contribute to ischaemic acidotoxicity. We have examined the role of ASIC1a in AMPAR ischaemic plasticity in organotypic hippocampal slice cultures exposed to oxygenglucose deprivation (a model of ischaemic stroke), and in hippocampal pyramidal neuron cultures exposed to acidosis. We find that ASIC1a activation promotes both forms of AMPAR plasticity and that neuroprotection, by inhibiting ASIC1a, circumvents any further benefit of blocking CP-AMPARs. Our observations establish a new interaction between acidotoxicity and excitotoxicity, and provide insight into the role of ASIC1a and CP-AMPARs in neurodegeneration. Specifically, we propose that ASIC1a activation drives certain post-ischaemic forms of CP-AMPAR plasticity. ABSTRACT: The CA1 region of the hippocampus is particularly vulnerable to ischaemic damage. While NMDA receptors play a major role in excitotoxicity, it is thought to be exacerbated in this region by two forms of post-ischaemic AMPA receptor (AMPAR) plasticity - namely, anoxic long-term potentiation (a-LTP), and a delayed increase in the prevalence of Ca(2+) -permeable GluA2-lacking AMPARs (CP-AMPARs). The acid-sensing ion channel 1a (ASIC1a), which is expressed in CA1 pyramidal neurons, is also known to contribute to post-ischaemic neuronal death and to physiologically induced LTP. This raises the question does ASIC1a activation drive the post-ischaemic forms of AMPAR plasticity in CA1 pyramidal neurons? We have tested this by examining organotypic hippocampal slice cultures (OHSCs) exposed to oxygenglucose deprivation (OGD), and dissociated cultures of hippocampal pyramidal neurons (HPNs) exposed to low pH (acidosis). We find that both a-LTP and the delayed increase in the prevalence of CP-AMPARs are dependent on ASIC1a activation during ischaemia. Indeed, acidosis alone is sufficient to induce the increase in CP-AMPARs. We also find that inhibition of ASIC1a channels circumvents any potential neuroprotective benefit arising from block of CP-AMPARs. By demonstrating that ASIC1a activation contributes to post-ischaemic AMPAR plasticity, our results identify a functional interaction between acidotoxicity and excitotoxicity in hippocampal CA1 cells, and provide insight into the role of ASIC1a and CP-AMPARs as potential drug targets for neuroprotection. We thus propose that ASIC1a activation can drive certain forms of CP-AMPAR plasticity, and that inhibiting ASIC1a affords neuroprotection.
anoxic LTPAMPA receptoracid‐sensing ion channel 1acalcium‐permeable AMPARhippocampal pyramidal neuroncurrent–voltageknockoutlong‐term potentiation1‐naphthyl acetyl sperminenuclear factor of activated T cellsNMDA receptoroxygenglucose deprivationorganotypic hippocampal slice culturepsalmotoxin 1propidium iodiderectification indextheta‐burst stimulationwild type
Introduction
During ischaemia, the excessive release of the excitatory neurotransmitter
glutamate leads to neuronal toxicity and death, in part due to over‐activation of ligand gated ion
channels and the resultant calcium entry. While early work suggested that excitotoxicity due to
excessive activation of NMDA receptors (NMDARs) was the main cause of neuronal death in the
ischaemic brain, it has become apparent that the situation is more complex, involving activation or
alteration of a host of ionotropic receptors and channels (Szydlowska & Tymianski, 2010), including calcium‐permeable AMPA receptors
(CP‐AMPARs) (Pellegrini‐Giampietro et al. 1992; Opitz et al. 2000; Tanaka et al. 2002; Noh et al. 2005) and acid‐sensing ion channels (ASICs) activated
by the increased protons associated with ischaemia (Xiong et al. 2004; Pignataro et al. 2007; Mari et al. 2010; Sherwood et al. 2011). How these different membrane channels contribute
and interact to confer ischaemic susceptibility is still poorly understood.The hippocampal CA1 area is critical for several types of memory and learning
(Bartsch et al. 2011; Goshen
et al. 2011). CA1 hippocampal
pyramidal neurons (HPNs) are particularly susceptible to ischaemia, which has long been known to
trigger their delayed death in humans and animal models (Kirino, 1982; Petito et al. 1987). Two forms of post‐ischaemic AMPA receptor plasticity have been
suggested to intensify the excitotoxicity that occurs within the CA1 region, and to contribute to
the HPN delayed degeneration. First, there is a persistent enhancement in glutamatergic
neurotransmission, the anoxic long‐term potentiation (a‐LTP), which occurs within the first hour
following ischaemia (Hsu & Huang, 1997; Kawai
et al. 1998; Quintana
et al. 2006; Dias
et al. 2013). Second, there is
evidence for a downregulation of GluA2 expression several hours later. This is accompanied by
enhanced expression of Ca2+‐permeable GluA2‐lacking AMPARs (CP‐AMPARs)
(Pellegrini‐Giampietro et al. 1992; Opitz et al. 2000; Tanaka et al. 2002; Noh et al. 2005). Pharmacological block of CP‐AMPARs with
1‐naphthyl acetyl spermine (NASPM) has been shown to provide a striking time window of ∼40 h of
neuroprotection in the CA1 area (Noh et al. 2005), in keeping with the view that these CP‐AMPARs play a critical role in
cell death. It is of note that CP‐AMPARs are expressed during normal LTP at CA1 synapses although in
these conditions they are present only transiently (Plant et al. 2006; Morita et al. 2014; but see Adesnik & Nicoll, 2007).Hippocampal pyramidal neurons in CA1 also express the sodium‐ and calcium‐permeable
ASIC1a channels (Wemmie et al. 2013). Previous studies have demonstrated that following focal ischaemia, the pH typically
falls to 6.5–6.0 under normo‐glycaemic conditions and can fall below 6.0 during severe ischaemia or
hyperglycaemia (Siesjo, 1982; Rehncrona, 1985; Nedergaard et al. 1991). More recent work has demonstrated the
involvement of ASIC1a homomers and ASIC1a/2b heteromers (channels we refer to here as ASIC1a) in the
neurotoxicity induced by ischaemic acidosis (acidotoxicity), possibly due to their calcium
permeability (Xiong et al. 2004;
Pignataro et al. 2007; Mari
et al. 2010; Sherwood
et al. 2011). Thus, ASIC1a
blockers or knockout (KO) of the ASIC1a gene provides significant neuroprotection in
vivo (Xiong et al. 2004; Pignataro et al. 2007). In CA1HPNs, this deleterious role of ASIC1a is exacerbated by its functional
coupling with NMDA receptors (NMDARs; Gao et al. 2005). One of the physiological roles of ASIC1a appears to be regulation of
AMPAR synaptic plasticity. Thus, loss of ASIC1a in KO mice impairs activity‐dependent LTP, without
modification of basal AMPAR‐mediated neurotransmission both in CA1 cells (Wemmie
et al. 2002) and in lateral
amygdala (Du et al. 2014).Here we have examined the possibility that ASIC1a activation can promote
post‐ischaemic AMPAR plasticity in CA1HPNs, and may play a role in the vulnerability of this region
to anoxic injury.
Methods
Ethical approval
For hippocampal pyramidal neuron cultures, rats were killed by decapitation in
accordance with the UK Animals (Scientific Procedures) Act 1986. For organotypic hippocampal slice
cultures, mice were killed by decapitation, using a protocol approved by the Geneva and Vaud
Veterinarian Office.
Organotypic slice cultures and anoxia/hypoglycaemia induction
ASIC1a KO mice were kindly provided by Michael Welsh. The knockout ablates all
ASIC1a‐containing channels and is therefore expected to result in loss of calcium‐permeable ASIC1a
channel (ASIC1a homomers and ASIC1a/2b heteromers) and the Ca2+‐impermeable ASIC1a/2a
heteromers. Organotypic hippocampal slice cultures (OHSCs) from 4‐ to 5‐day‐old mouse (P4–5) were
prepared and maintained for 10–15 days as described previously (Stoppini et al.
1991). Oxygenglucose deprivation (OGD) was
induced for 10 min as previously described (Quintana et al. 2006). Briefly, slices were placed in a homemade
chamber and continuously perfused with artificial cerebrospinal fluid (ACSF) using a peristaltic
pump with a flow rate of 2.5–3 ml min−1, temperature 35 ± 1°C. Control slices were
exposed to ACSF containing (in mm): NaCl, 124; CaCl2, 2.5; MgCl2,
1.5; KCl, 1.6; KH2PO4, 1.2; NaHCO3, 24; glucose, 10; ascorbic acid,
2; pH 7.4, and bubbled with 95% O2–5% CO2. OGD was induced by replacing
glucose with sucrose and by bubbling with 95% N2–5% CO2. In some experiments,
psalmotoxin 1 (PcTx1, 100 nm, Pepta Nova, Sandhausen, Germany) was added in the medium or
the extracellular solution (ACSF). At the concentration used this is expected to selectively block
the calcium‐permeable ASIC1a channel (ASIC1a homomers and ASIC1a/2b heteromers), leaving
calcium‐impermeable channels unaffected.
Hippocampal pyramidal neuron culture and acidosis treatment
Cultured hippocampal neuronal (HPNs) were prepared from P1 Wistar rats using a
previously described protocol with minor modifications (Hudmon et al. 2005). Cells were grown on glass coverslips or in 10 cm
Petri dishes. Experiments were carried on cells 14–21 days in vitro (DIV). For
experiments involving acidosis, after a quick wash with pH 7.4 solution, HPNs were challenged for
15 min with extracellular solution of different pH (pH 7.4 for controls, and pH 6.0 for acidosis)
containing (in mm): NaCl, 145; KCl, 2.5; CaCl2, 1; MgCl2, 1; glucose,
10; Hepes, 10; Mes, 10. PcTx1 (20 nm) was added in the extracellular solution for some
experiments.
Electrophysiology on slices
AMPAR‐mediated fEPSPs and EPSCs were recorded as previously described (Quintana
et al. 2006). Slices were placed
in a homemade chamber and perfused with ACSF. For EPSPs, two recordings were made in parallel on the
same slices with pipettes containing ACSF. The average of the two recordings was used for analysis.
EPSP slope was defined as the maximum slope (dV/dt) of the initial
portion of the response and was measured for all individual responses. Results were normalized to
the average slope of fEPSPs recorded before OGD, and plotted as a function of time. fEPSPs were pure
AMPAR‐mediated responses in our experimental conditions as NBQX (10 μm, Alexis
Biochemicals, San Diego, CA, USA) suppressed the response (data not shown). EPSCs were measured in
the presence of bicuculline (25 μm; Tocris Bioscience, Bristol, UK) or picrotoxin
(100 μm; Tocris Bioscience), and d‐2‐amino‐5‐phosphonovalerate (d‐AP5,
50 μm; Alexis Biochemicals) to block respectively the GABAA and NMDA receptors.
Spermine tetrahydrochloride (100 μm, Tocris Bioscience) was added in the pipette solution
(Kamboj et al. 1995). Average
fEPSPs and EPSCs were obtained by aligning a minimum of five events (IGOR Pro, Wavemetrics Inc.,
Lake Oswego, OR, USA).
Electrophysiology on HPNs
Twelve to twenty‐four hours after treatment, AMPAR currents were evoked in
outside‐out patches by rapid application of 10 mm glutamate (100 ms pulses) as previously
described (Soto et al. 2009),
with 50 μm d‐AP5 added in the extracellular solution to block NMDA receptors. Average
waveforms for illustration and analysis were generated after aligning a minimum of 20 events
(NeuroMatic, IGOR Pro). Single‐channel conductance (γ, pS) was estimated using non‐stationary
fluctuation analysis as previously described (Soto et al. 2009).
Assessment of neuronal injury in OHSCs and HPNs
In experiments on OHSCs, we used propidium iodide (PI) uptake to assess cell
injury. PI (5 μg ml−1) was added to the culture medium for 30 min to check slice
viability before OGD or control treatment; OHSCs with significant staining were excluded from
further analysis. Image acquisition was performed 12 and 24 h after OGD using an inverted
fluorescence microscope (Axiovert, Zeiss), with a 2.5× magnification objective and a digital camera
(Axiocam HRc, Zeiss). PI fluorescence was quantified in the CA1 region (arbitrary units) using
ImageJ software (NIH) and the equivalent average signal in controls was subtracted from the value in
OGD exposed slices. For each condition the signal of the different slices
(n = 6–12/experiment) was averaged and a percentage of neuroprotection (NP)
corresponding to the relative decrease in PI uptake induced by the blocker(s) compared with the OGD
condition was calculated as follows:where Avg stands for average and Upt stands for
Uptake.The values obtained for the different experiments (n = 3 cultures)
were averaged to obtain the final data. For ASIC1a KO OHSCs, experiments were repeated 4 times with
3–4 slices/experiment and image acquisition was performed at 2 and 24 h after OGD.HPN cultures on coverslips were exposed to the different experimental solutions and
stained 24 h post‐treatment with anti‐caspase‐3 (Asp175) (5A1E, Cell Signaling Technology, Danvers,
MA, USA) and examined for nuclear fragmentation using DAPI staining (n = 6
coverslips per condition). Quantification was performed with ImageJ.
Western blotting and cell surface biotinylation
We performed Western blotting (WB) on protein extracts from OHSCs as previously
described with minor modifications (Quintana et al. 2006). OHSCs (3–4 independent cultures corresponding to 6–14 culture inserts
per condition with 5–8 slices per insert) were collected and lysed in ice‐cold lysis buffer with
Complete protease inhibitor mix (Roche). We used anti‐GluA1antibody (1:1000, Millipore, cat. no.
04–855), anti‐GluA2 antibody (1:1000, Millipore, cat. no. MAB397), anti‐actin antibody (1:5000,
Sigma, cat. no. A5316), and anti‐NeuN (1:500, Millipore, cat. no. MAB377). For NeuN we quantified
only the two major species at 46–48 kDa identified as Fox‐3 (Dent et al. 2010). GluA1, GluA2 and NeuN were quantified by
normalizing to the respective actin bands. Immunoblots were visualized by ECL development (GE
Healthcare Life Sciences) and using either films or the ChemiDoc MP System. The total levels of
GluA1, GluA2 and NeuN were quantified by normalizing to the respective actin bands. For the
quantification of the total GluA1/GluA2 ratio, to ensure consistency the same protein concentration
was loaded; in addition each Western blot image was captured for identical lengths of time.HPNs were grown in 10 cm Petri dishes and cell surface biotinylation was performed
as previously described (Soto et al. 2009).
Statistics
Data are expressed as means ± SEM. Statistical analyses were performed using
GraphPad Prism (GraphPad Software Inc., La Jolla, CA, USA). We tested the distribution and the
standard deviation of our datasets using the Shapiro‐Wilk normality test. We used unpaired Student's
t test (parametric) or the Mann‐Whitney U test (non‐parametric) to
compare pairs. To compare multiple experimental conditions, we used one‐way ANOVA (parametric)
followed by Tukey's multiple comparison test or the Kruskal‐Wallis test (non‐parametric) followed by
Dunn's multiple comparisons test.
Results
Anoxic LTP is ASIC1a dependent
To determine whether ASIC1a activation, during anoxia, influences AMPAR plasticity
changes, we have tested whether a‐LTP is ASIC1a dependent. We measured AMPAR‐mediated field
excitatory postsynaptic potentials (fEPSPs) in the stratum radiatum of the CA1 region of organotypic
hippocampal slice cultures (OHSCs) prepared from wild‐type (WT) and ASIC1a knockout (KO) mice
(Wemmie et al. 2002).To validate OHSCs as a model to study the role of ASIC1a in synaptic plasticity, we
first tested the involvement of ASIC1a in theta‐burst stimulation (TBS)‐induced LTP. In WT slices,
TBS (five trains at 5 Hz composed each of four pulses at 100 Hz, repeated three times at 10 s
interval) was followed by a prolonged increase in fEPSP slope (average slope 45–50 min after
TBS/average baseline = 1.52 ± 0.1, n = 4) which was absent in KO slices (slope
ratio = 0.97 ± 0.1, n = 5) (Fig. 1
A), as previously described with acute slices (Wemmie et al. 2002). To induce a‐LTP, OHSCs were exposed for 10 min
to conditions of oxygenglucose deprivation (OGD) (Fig. 1
B), a validated model of brain ischaemia. We have previously shown that this
treatment induces a robust AMPAR‐mediated neurotransmission potentiation without increasing AMPAR
rectification (Quintana et al. 2006). As expected from these observations, OGD treatment of WT slices induced a prolonged
increase of fEPSP slope (average slope 45–50 min after OGD/average baseline = 1.97 ± 0.3,
n = 3, Fig. 1
C). However, a‐LTP was absent in slices from ASIC1a KO animals (slope
ratio = 0.85 ± 0.1, n = 4, Fig. 1
C).
Figure 1
Anoxic LTP relies on ASIC1a in OHSCs
A, theta‐burst stimulation (TBS) induced changes in the slope of AMPAR‐mediated
fEPSPs measured in the CA1 stratum radiatum of OHSCs from WT (○, n = 4) and ASIC1a
KO (●, n = 5) mice. Inset: representative baseline (black trace) and 30 min after
TBS (grey trace) recordings; Scale bars: 25 ms and 1 mV. B, experimental protocol
for a‐LTP experiments. C, changes of fEPSP slope induced by 10 min OGD in WT (○,
n = 3) and ASIC1a KO (●, n = 4) OHSCs. The increase in slope
observed in WT corresponds to a‐LTP. Inset: representative traces before (black trace) and 30 min
after OGD (grey trace). Scale bars: 25 ms and 1 mV. D, representative Western blots
showing changes in GluA2 subunit expression 1 h after OGD. OHSCs from WT or ASIC1a KO animals were
exposed either to control (−) or to OGD (+) conditions. Some WT slices were treated with psalmotoxin
1 (PcTx1, 100 nm) during or after OGD; actin was used for normalization.
E, relative GluA2 subunit abundance compared with controls expressed as a
percentage (n = 6–14). Error bars, SEM; *P < 0.05; n.s., not
significant.
Anoxic LTP relies on ASIC1a in OHSCs
A, theta‐burst stimulation (TBS) induced changes in the slope of AMPAR‐mediated
fEPSPs measured in the CA1 stratum radiatum of OHSCs from WT (○, n = 4) and ASIC1a
KO (●, n = 5) mice. Inset: representative baseline (black trace) and 30 min after
TBS (grey trace) recordings; Scale bars: 25 ms and 1 mV. B, experimental protocol
for a‐LTP experiments. C, changes of fEPSP slope induced by 10 min OGD in WT (○,
n = 3) and ASIC1a KO (●, n = 4) OHSCs. The increase in slope
observed in WT corresponds to a‐LTP. Inset: representative traces before (black trace) and 30 min
after OGD (grey trace). Scale bars: 25 ms and 1 mV. D, representative Western blots
showing changes in GluA2 subunit expression 1 h after OGD. OHSCs from WT or ASIC1a KO animals were
exposed either to control (−) or to OGD (+) conditions. Some WT slices were treated with psalmotoxin
1 (PcTx1, 100 nm) during or after OGD; actin was used for normalization.
E, relative GluA2 subunit abundance compared with controls expressed as a
percentage (n = 6–14). Error bars, SEM; *P < 0.05; n.s., not
significant.Our previous data have also demonstrated that the maintenance of a‐LTP requires the
synthesis of new GluA2 subunits (Quintana et al. 2006). Accordingly, we observed a significant increase in GluA2 expression 1 h
after OGD in WT slices (GluA2OGD/GluA2control = 1.31 ± 0.08,
n = 8, P < 0.05, Fig. 1
D and E). Importantly, the increase in GluA2 expression was not
apparent in ASIC1a KO slices (n = 7, Fig. 1
D and E) in agreement with the electrophysiology data. In
addition, the ASIC1a‐specific inhibitor psalmotoxin 1 (PcTx1, 100 nm) blocked the
upregulation of GluA2 in slices from WT mice if present during (n = 6) but not
after (n = 14) OGD (Fig. 1
D and E). These results suggest that ASIC1a activation, during
OGD, plays a role in the development and maintenance of ischaemia‐induced a‐LTP and the associated
increase in AMPAR expression.
OGD induced prevalence of CP‐AMPARs is ASIC1a dependent
Ischaemia has been shown to induce a delayed increase in the expression of
CP‐AMPARs in CA1 neurons due to a depression of GluA2 subunit expression in various animal models
(Pellegrini‐Giampietro et al. 1992; Opitz et al. 2000; Tanaka et al. 2002; Noh et al. 2005). In our initial experiments, we tested if this
could be reproduced ex vivo in OHSCs exposed to OGD. We observed that the CP‐AMPAR
channel blocker NASPM (100 μm) did not affect the fEPSP slope measured before (0 h) or 6 h
after OGD (ratio = slope after NASPM/before NASPM; ratio0h = 0.97 ± 0.03,
n = 7; ratio6h = 0.93 ± 0.06, n = 3). However, by 12 h
post‐OGD, NASPM significantly inhibited the response, confirming a delayed rise in synaptic
CP‐AMPARs (ratio12h = 0.65 ± 0.11, n = 4, P < 0.05),
similar to that described in vivo (Noh et al. 2005) (Fig. 2
A–C).
Figure 2
OGD induced increase of CP‐AMPARs is ASIC1a dependent in slice cultures
A, experimental protocol. B and C, effect of
NASPM (100 μm) on fEPSP slope before (0 h), 6 h after, and 12 h after OGD. Representative
recordings (B), before (black traces) and after (grey traces) application of NASPM;
scale bar, 25 ms and 0.5 mV. fEPSP slope ratio (C), after vs.
before NASPM. D–I, changes in AMPAR‐mediated EPSCs recorded in CA1 neurons in cells
derived from WT (D–F, n = 4–6) and ASIC1a KO
(G–I, n = 4) mice. D and G,
representative EPSC traces at +40 and −70 mV recorded 6 h (left hand side) and 12 h (right) after
10 min OGD treatment; scale bar, 25 ms and 25 pA. E and H,
current–voltage plots at 6 h and 12 h after OGD. F and I, EPSC
rectification index; RI+40/−40 = EPSC amplitude at +40 mV/−40 mV. J and
K, changes in GluA2 subunit expression 12 h after OGD treatment. Cells from WT or
ASIC1a KO animals were exposed either to control (−) or to OGD (+) conditions. Some WT slices were
treated with psalmotoxin 1 (PcTx1, 100 nm) during or after OGD. J,
representative Western blots, obtained for GluA2 subunits, NeuN and actin (for normalization). NeuN
level is relatively stable. K, relative GluA2 abundance, compared with controls
expressed as a percentage (n = 8–10). Error bars, SEM;
*P < 0.05, **P < 0.005, ***P < 0.0005;
n.s., not significant.
OGD induced increase of CP‐AMPARs is ASIC1a dependent in slice cultures
A, experimental protocol. B and C, effect of
NASPM (100 μm) on fEPSP slope before (0 h), 6 h after, and 12 h after OGD. Representative
recordings (B), before (black traces) and after (grey traces) application of NASPM;
scale bar, 25 ms and 0.5 mV. fEPSP slope ratio (C), after vs.
before NASPM. D–I, changes in AMPAR‐mediated EPSCs recorded in CA1 neurons in cells
derived from WT (D–F, n = 4–6) and ASIC1a KO
(G–I, n = 4) mice. D and G,
representative EPSC traces at +40 and −70 mV recorded 6 h (left hand side) and 12 h (right) after
10 min OGD treatment; scale bar, 25 ms and 25 pA. E and H,
current–voltage plots at 6 h and 12 h after OGD. F and I, EPSC
rectification index; RI+40/−40 = EPSC amplitude at +40 mV/−40 mV. J and
K, changes in GluA2 subunit expression 12 h after OGD treatment. Cells from WT or
ASIC1a KO animals were exposed either to control (−) or to OGD (+) conditions. Some WT slices were
treated with psalmotoxin 1 (PcTx1, 100 nm) during or after OGD. J,
representative Western blots, obtained for GluA2 subunits, NeuN and actin (for normalization). NeuN
level is relatively stable. K, relative GluA2 abundance, compared with controls
expressed as a percentage (n = 8–10). Error bars, SEM;
*P < 0.05, **P < 0.005, ***P < 0.0005;
n.s., not significant.To investigate the potential role of ASIC1a in this process, we examined evoked
excitatory postsynaptic currents (EPSCs) in whole‐cell recordings from CA1 neurons in OHSCs from WT
and ASIC1a KO mice 6 and 12 h after OGD (Fig. 2
D–I). The presence of EPSCs mediated by CP‐AMPARs was readily identified from their
inwardly rectifying current–voltage (I–V) relationships and low rectification index
(RI; amplitude EPSC at +40 mV/amplitude EPSC at −40 mV) when intracellular polyamine (spermine,
100 μm) was included in the patch pipette (Kamboj et al. 1995).In WT neurons there was an increase in inward rectification of EPSCs, and a
significant drop in their RI at 12 vs. 6 h post OGD (RI6h = 0.97 ± 0.08,
RI12h = 0.53 ± 0.07, P < 0.005, n = 4–6, Fig. 2
D–F), indicating a time‐dependent rise in the proportion of synaptic CP‐AMPARs. As
previously noted in vivo, this change was associated with a clear downregulation of
the GluA2 subunit (GluA2OGD/ GluA2control = 0.59 ± 0.06,
n = 8, P < 0.0005, Fig. 2
J and K). The neuron specific protein NeuN decreased significantly
12 h after OGD reflecting neuron death (NeuNOGD/NeuNcontrol = 0.8 ± 0.06,
P < 0.05, n = 8, Fig. 2
J). However, we found no positive correlation between the level of GluA2 and NeuN
(R
2 = 0.53) suggesting that neuron death was not the primary cause of the reduction in the
GluA2 level. The absence of ASIC1a channels or their block by PcTx1, during or after OGD, suppressed
these AMPAR changes (Fig. 2
G–K) suggesting that ASIC1a activation, during and after OGD, is necessary for the
late increase in GluA2‐lacking CP‐AMPARs.Despite convergent evidence indicating an increase in CP‐AMPARs, we found that
GluA1 appeared to be similarly downregulated in WT slices exposed to OGD
(GluA1OGD/GluA1control = 0.62 ± 0.04, n = 8,
P < 0.0005, Fig. 3). And like
GluA2, in all other conditions it was not significantly changed (P > 0.5). Thus,
we found no change following OGD in ASIC1a KO slices
(GluA1OGD/GluA1control = 1.12 ± 0.23, n = 9), or in WT mice
when OGD was followed by PcTx1 (GluA1OGD/GluA1control = 0.82 ± 0.05,
n = 10), or accompanied by PcTx1 (GluA1OGD/
GluA1control = 0.79 ± 0.11, n = 8). To clarify this point and assess the
mechanisms underlying the delayed changes in AMPARs, we next performed experiments on purified
cultures of hippocampal pyramidal neurons (HPNs).
Figure 3
GluA1 subunit is downregulated in OHSCs exposed to OGD
A and B, changes in GluA1 subunit expression 12 h after OGD
treatment. OHSCs from WT animals were exposed either to control (−) or to OGD (+) conditions.
A, Western blots, obtained for GluA1 subunits, GluA2 subunits and actin (for
normalization) in three representative experiments (Exp. 1–3). B, relative GluA1
abundance, compared with controls expressed in percentage (n = 8). GluA1 subunit
abundance decreases in a similar way to GluA2 in total protein extracts of OHSCs. Error bars, SEM;
***P < 0.0005.
GluA1 subunit is downregulated in OHSCs exposed to OGD
A and B, changes in GluA1 subunit expression 12 h after OGD
treatment. OHSCs from WT animals were exposed either to control (−) or to OGD (+) conditions.
A, Western blots, obtained for GluA1 subunits, GluA2 subunits and actin (for
normalization) in three representative experiments (Exp. 1–3). B, relative GluA1
abundance, compared with controls expressed in percentage (n = 8). GluA1 subunit
abundance decreases in a similar way to GluA2 in total protein extracts of OHSCs. Error bars, SEM;
***P < 0.0005.
H+ activation of ASIC1a is sufficient to induce an increase in CP‐AMPARs
There is evidence to suggest that neuronal ASIC1a can be activated by vesicular
protons co‐released with glutamate (Mari et al. 2010; Du et al. 2014; Kreple et al. 2014) and by the acidosis that follows stroke (Pignataro et al. 2007). To assess if proton activation of ASIC1a
channels in hippocampal pyramidal neurons (HPNs) will trigger the AMPAR switch, we measured the
I–V relationship of currents obtained in response to rapid applications of
glutamate (10 mm, 100 ms duration, in the presence of d‐AP5) to outside‐out
membrane patches from cultured HPNs. Our hippocampal cultures contained predominantly neurons (see
Fig. 6
D) and allowed rapid change of the cellular environment. These cells were exposed
to either an increased level of protons (pH 6.0 or 6.5) or normal physiological pH (7.4) for 15 min
(Fig. 4
A), and the AMPAR currents were examined 12 to 24 h after this treatment (Fig.
4
B–F).
Figure 6
Combining ASIC1a and CP‐AMPAR inhibitors does not provide further neuroprotection against
ischaemia or acidosis
A, evaluation of OGD‐induced degeneration in organotypic cultures with propidium
iodide (PI) uptake quantification. Representative pictures of PI uptake in slices at 12 and 24 h
after OGD. Scale bar = 250 μm. WT slices exposed to OGD were treated for the first 6 h with either
saline (control), PcTx1 (100 nm), NASPM (100 μm) or both inhibitors together.
B and C, quantification of the neuroprotection by ion channel
inhibitors in the CA1 region at 12 and 24 h after OGD. The percentage of neuroprotection was
calculated as detailed in Methods (n = 3 cultures, number of
slices/condition = 6–12). D, confocal images of hippocampal pyramidal cells 24 h
after a 15 min treatment with pH 7.4, pH 6.0, pH6.0 + PcTx1 (20 nm, during pH 6.0), pH 6.0
+ NBQX (10 μm, after pH 6.0), or pH 6.0 + PcTx1 and NBQX together. Top left, double
staining for MAP2 (green) and DAPI (blue) confirms the purity of HPN cultures. Other pictures,
neuronal injury and death in HPN cultures assessed with caspase‐3 cleaved form staining (red) and
the percentage of abnormal nuclei (stained in blue with DAPI) as markers. Scale bar = 25 μm. Typical
nuclei are indicated by an arrowhead and represented at high magnification in the right bottom
corner. E and F, quantification of the cleaved caspase‐3 signal,
and of the percentage of abnormal nuclei. G, representative images of propidium
iodide uptake in hippocampal slices from WT and ASIC1a knockout at 2 and 24 h after OGD.
H, pooled data showing the protective effect of ASIC1a knockout on OGD mediated
cell death (n = 4). Error bars, SEM; *P < 0.05,
**P < 0.005, ***P < 0.0005 vs. pH 7.4;
n.s., not significant.
Figure 4
Acidosis induces an ASIC1a‐dependent switch in AMPAR composition in cultured neurons
A, experimental protocol. B, I–V plots of AMPAR
currents measured in outside‐out patches from hippocampal pyramidal neurons (HPNs) exposed to pH 7.4
(control, ○, n = 3) or pH 6.0 (acidosis, ●, n = 7).
C, AMPAR current rectification index, in control cells and following pH 6.0
treatment; effect of pH 6.0 on RI is blocked by psalmotoxin 1, (PcTx1, 20 nm)
(RI+60/−60, n = 11–26). D, typical current traces at
+60 and −60 mV. For ease of comparison, currents at −60 mV are scaled to the same peak amplitude.
Upper traces: HPNs exposed to pH 7.4 (left) or pH 7.4 + PcTx1 (right). Lower traces: HPNs exposed to
pH 6.0 (left) or pH 6.0 + PcTx1 (right). E, AMPAR single‐channel conductance
(n = 7–16). F, bar graph comparing the effects of pH 6.0 treatment
in the presence of d‐AP5 (50 μm), cadmium (200 μm) and TTX
(1 μm) on AMPAR rectification index. G, Western blots of total and cell
surface expression of GluA2 in HPNs 12 h after treatment, characterized by cell surface
biotinylation followed by Western blotting (WB) (n = 8). H and
I, pooled data from pH 7.4 and pH 6.0 treated hippocampal cultures assayed for
total and surface (membrane) GluA2. Error bars, SEM; *P < 0.05,
**P < 0.005, ***P < 0.0005; n.s., not significant.
Acidosis induces an ASIC1a‐dependent switch in AMPAR composition in cultured neurons
A, experimental protocol. B, I–V plots of AMPAR
currents measured in outside‐out patches from hippocampal pyramidal neurons (HPNs) exposed to pH 7.4
(control, ○, n = 3) or pH 6.0 (acidosis, ●, n = 7).
C, AMPAR current rectification index, in control cells and following pH 6.0
treatment; effect of pH 6.0 on RI is blocked by psalmotoxin 1, (PcTx1, 20 nm)
(RI+60/−60, n = 11–26). D, typical current traces at
+60 and −60 mV. For ease of comparison, currents at −60 mV are scaled to the same peak amplitude.
Upper traces: HPNs exposed to pH 7.4 (left) or pH 7.4 + PcTx1 (right). Lower traces: HPNs exposed to
pH 6.0 (left) or pH 6.0 + PcTx1 (right). E, AMPAR single‐channel conductance
(n = 7–16). F, bar graph comparing the effects of pH 6.0 treatment
in the presence of d‐AP5 (50 μm), cadmium (200 μm) and TTX
(1 μm) on AMPAR rectification index. G, Western blots of total and cell
surface expression of GluA2 in HPNs 12 h after treatment, characterized by cell surface
biotinylation followed by Western blotting (WB) (n = 8). H and
I, pooled data from pH 7.4 and pH 6.0 treated hippocampal cultures assayed for
total and surface (membrane) GluA2. Error bars, SEM; *P < 0.05,
**P < 0.005, ***P < 0.0005; n.s., not significant.Compared with control cells, neurons exposed to pH 6.0 displayed inwardly
rectifying I–V plots indicative of the presence of CP‐AMPARs (Fig. 4
B). The rectification index of currents in patches (RI = current amplitude at
+60 mV/−60 mV) was reduced (from RIpH7.4 = 0.89 ± 0.03 to RIpH6 = 0.59 ± 0.04,
P < 0.0001, n = 23–26, Fig. 4
C and D), and the single‐channel conductance (γ), estimated from
non‐stationary fluctuation analysis (Soto et al. 2009), was roughly doubled (γpH7.4 = 12.33 ± 1.38 pS,
γpH6 = 24.14 ± 4.36 pS, P < 0.05, n = 15–17, Fig.
4
E). Strong inward rectification and a high single‐channel conductance are both
indicative of CP‐AMPARs. HPNs exposed to pH 6.5 did not exhibit significant changes in the
rectification index or single‐channel conductance of their AMPAR‐mediated currents
(RIpH6.5 = 0.89 ± 0.11, γpH6.5 = 14.61 ± 3.03; n = 6).Consistent with the view that CP‐AMPAR expression was increased 12 h after pH 6.0
acidosis, we found a significant decrease in GluA2 both at the cell surface and in total protein
expression (sGluA2pH6.0/sGluA2pH7.4 = 34.26 ± 7.2 %,
P < 0.005 and tGluA2pH6.0/tGluA2pH7.4 = 59.8 ± 10 %,
P < 0.05, n = 8, Fig. 4
H–I ). Application of PcTx1 (20 nm) during pH 6.0 treatment was able to
suppress these changes, and changes in rectification and single‐channel conductance
(RIpH6+PcTx1 = 0.80 ± 0.06, n = 16, γpH6+PcTx1 = 16.11 ± 2.45
pS, n = 10, Fig. 4
C–E).ASIC stimulation depolarizes the membrane potential of hippocampal neurons,
modulating voltage‐gated ion channel and NMDAR activation. To test if this influenced the
ASIC‐induced switch in AMPAR composition, we included selective ion channel blockers in the pH 6.0
solution. The block of voltage‐gated calcium channels (VGCCs) by cadmium (Cd 200 μm)
(RIpH6+Cd = 0.69 ± 0.10, γpH6+Cd = 21.91 ± 4.72 pS, n = 14,
Fig. 4
F) and of NMDARs by d‐AP5 (50 μm)
(RIpH6+AP5 = 0.70 ± 0.06, γpH6+AP5 = 16.99 ± 2.68 pS, n = 16,
Fig. 4
F) partially suppressed the change in AMPAR properties. Inhibiting both VGCCs and
NMDARs almost completely blocked the AMPAR subunit switch induced by ASIC1a activation
(RIpH6+Cd+AP5 = 0.85 ± 0.06, n = 16,
γpH6+Cd+AP5 = 14.72 ± 1.82 pS, n = 13, Fig. 4
F). However, blocking sodium channels with tetrodotoxin (TTX 1 μm) did not
inhibit the change (RIpH6+TTX = 0.57 ± 0.06, γpH6+TTX = 22.04 ± 3.10 pS,
n = 16, Fig. 4
F). These results suggest that modulation of Ca2+‐permeable NMDARs and
VGCCs by ASIC1a activation is critical in triggering the observed AMPAR plasticity, suggesting
Ca2+ influx is required for the loss of GluA2 expression detected following
acidification.We extended these findings by examining the effects of acidosis on the expression
levels of GluA1 (Fig. 5), and found no alteration
in either the total (Fig. 5
C) or cell surface GluA1 (Fig. 5
B). Consequently, proton activation of ASIC1a channels increased the ratio of total
GluA1/total GluA2 from 0.70 ± 0.12 to 2.0 ± 0.32 (P < 0.05,
n = 5, Fig. 5
D), suggesting the observed switch from Ca2+‐impermeable to CP‐AMPARs in
HPNs can be ascribed to a relative decrease in GluA2.
Figure 5
Acidification does not alter GluA1 expression in pyramidal neurons
A, Western blot analysis of total and cell surface GluA1 from cultured hippocampal
pyramidal neurons (HPNs) 12 h after exposure to either pH 7.4 or pH 6.0. B and
C, pooled data from 5 independent cell surface biotinylation experiments
demonstrating no change in cell surface expression of GluA1 following acidification
(P > 0.05, n = 5). D, Western blot analysis of
the ratio of total protein expression level of GluA1 to the total of GluA2 (GluA1/GluA2) following
acidification. This ratio increased significantly (0.70 ± 0.12 to 2.0 ± 0.32;
P < 0.05, n = 5).
Acidification does not alter GluA1 expression in pyramidal neurons
A, Western blot analysis of total and cell surface GluA1 from cultured hippocampal
pyramidal neurons (HPNs) 12 h after exposure to either pH 7.4 or pH 6.0. B and
C, pooled data from 5 independent cell surface biotinylation experiments
demonstrating no change in cell surface expression of GluA1 following acidification
(P > 0.05, n = 5). D, Western blot analysis of
the ratio of total protein expression level of GluA1 to the total of GluA2 (GluA1/GluA2) following
acidification. This ratio increased significantly (0.70 ± 0.12 to 2.0 ± 0.32;
P < 0.05, n = 5).
Combined inhibition of ASIC1a and CP‐AMPARs does not enhance neuroprotection
Block of either ASIC1a channels or CP‐AMPARs is known to reduce drastically cell
death following stroke (Xiong et al. 2004; Noh et al. 2005;
Pignataro et al. 2007). We
therefore considered whether the combined use of ASIC1a and AMPAR blockers produced an additive
effect in sparing neurons from damage (Fig. 6).
To estimate the degree of neuron death following OGD in OHSCs, we measured propidium iodide (PI)
uptake at 12 and 24 h after OGD (Fig. 6
A).
Combining ASIC1a and CP‐AMPAR inhibitors does not provide further neuroprotection against
ischaemia or acidosis
A, evaluation of OGD‐induced degeneration in organotypic cultures with propidium
iodide (PI) uptake quantification. Representative pictures of PI uptake in slices at 12 and 24 h
after OGD. Scale bar = 250 μm. WT slices exposed to OGD were treated for the first 6 h with either
saline (control), PcTx1 (100 nm), NASPM (100 μm) or both inhibitors together.
B and C, quantification of the neuroprotection by ion channel
inhibitors in the CA1 region at 12 and 24 h after OGD. The percentage of neuroprotection was
calculated as detailed in Methods (n = 3 cultures, number of
slices/condition = 6–12). D, confocal images of hippocampal pyramidal cells 24 h
after a 15 min treatment with pH 7.4, pH 6.0, pH6.0 + PcTx1 (20 nm, during pH 6.0), pH 6.0
+ NBQX (10 μm, after pH 6.0), or pH 6.0 + PcTx1 and NBQX together. Top left, double
staining for MAP2 (green) and DAPI (blue) confirms the purity of HPN cultures. Other pictures,
neuronal injury and death in HPN cultures assessed with caspase‐3 cleaved form staining (red) and
the percentage of abnormal nuclei (stained in blue with DAPI) as markers. Scale bar = 25 μm. Typical
nuclei are indicated by an arrowhead and represented at high magnification in the right bottom
corner. E and F, quantification of the cleaved caspase‐3 signal,
and of the percentage of abnormal nuclei. G, representative images of propidium
iodide uptake in hippocampal slices from WT and ASIC1a knockout at 2 and 24 h after OGD.
H, pooled data showing the protective effect of ASIC1a knockout on OGD mediated
cell death (n = 4). Error bars, SEM; *P < 0.05,
**P < 0.005, ***P < 0.0005 vs. pH 7.4;
n.s., not significant.As previously described (Ahlgren et al. 2011), the OGD induced injury of CA1 cells was already
evident within 12 h and had increased dramatically by 24 h. We then estimated the percentage of
neuroprotection (see Methods) provided by inclusion in the bathing medium of PcTx1 (100 nm)
during the first 6 h after OGD, or by NASPM (100 μm) after the first 6 h, when applied
either alone or successively (Fig. 6
A). The presence of PcTx1 produced a clear decrease in cell death at 12 and 24 h
(NP12h = 45.71 ± 2.68%, NP24h = 55.03 ± 5.82%, n = 3
experiments with 6–12 slices/experiment; Fig. 6
B and C). By contrast, while NASPM provide some protection at
12 h, it was less effective than PcTx1 (NP12h = 21.16 ± 6.78%, Fig. 6
B and C). By 24 h, it appeared to be roughly as effective as PcTx1
(NP24h = 45.11 ± 2.95%). This is likely to reflect the delayed increase in CP‐AMPARs.
However, when NASPM and PcTx1 were applied together they did not appear to provide more protection
than PcTx1 alone (NP12h = 44.46 ± 7.58%, NP24h = 52.56 ± 3.94%) (Fig. 6
B and C). This is consistent with our finding that the presence of
PcTx1 after OGD effectively suppressed the increased expression in CP‐AMPARs.To confirm the role of ASIC1a in OGD induced cell death, we examined PI uptake in
CA1 from WT (control) and ASIC1a KO hippocampal slices following OGD (Fig. 6
G and H).There was a clear decrease in cell death at 2 and 24 h after OGD treatment
in the ASIC1a KO tissue, when compared with WT (NP2h = 35.41 ± 9.33 % and
NP24h = 51.00 ± 6.39 %; n = 4 experiments, Fig. 6
H). These data indicate that ASIC1a KO affords some neuroprotection, in agreement
with our hypothesis.To examine this issue further, we counted nuclear abnormalities (nuclei stained
with DAPI) and measured cleaved caspase‐3 staining in cultured HPNs. Neuron injury was assessed 24 h
after acidosis (pH 6.0 for 15 min) (Fig. 6
D, n = 6 coverslips per condition). Neurons exposed to pH 6.0
exhibited an increased level of cleaved caspase‐3 expression (P < 0.005) and an
increased density of abnormal nuclei (P < 0.005) (Fig. 6
E and F) compared with controls (pH 7.4). When PcTx1
(20 nm) was included during exposure to pH 6.0, neuronal damage was significantly reduced
(P < 0.005 for both markers, Fig. 6
E and F). Furthermore, inclusion of the potent AMPAR blocker NBQX
(10 μm) after exposure to pH 6.0 also provided protection from cell death
(P < 0.05 for nuclei, and P < 0.005 for caspase‐3, Fig.
6
E and F). However, blocking both ASIC1a and CP‐AMPARs together did
not bring significant further protection compared with block of ASIC1a channels alone
(P > 0.05, n = 6 coverslips per condition, Fig. 6
E and F). These results are consistent with the view that
activation of ASIC1a channels during OGD is critical in driving hippocampal neuron damage.
Discussion
Our experiments have established that ASIC1a channels play a key role in AMPAR
plasticity in conditions of ischaemia or acidosis in HPNs. We find that ASIC1a activation is
critical for development and maintenance of a‐LTP in CA1 neurons. Furthermore, activation of ASIC1a
channels is necessary and sufficient to trigger the deleterious increase in CP‐AMPARs that occurs
following ischaemia or acidosis. Consistent with these results, we observed that inhibiting ASIC1a
circumvented the potential neuroprotective benefit afforded by the use of CP‐AMPAR blockers.We demonstrated that ASIC1a activation is necessary for the pathological form of
synaptic plasticity, a‐LTP, and confirmed its role in activity‐dependent LTP in CA1 cells (Wemmie
et al. 2002). These results are
consistent with previous studies suggesting these two forms of plasticity share a number of common
features including NMDAR dependence (Hsu & Huang, 1997; Quintana et al. 2006). Therefore, ASIC1a might contribute to a‐LTP by facilitating activation of the NMDARs
as suggested for activity‐dependent LTP (Wemmie et al. 2002). It is also of note that ASIC1a channels are permeable to both
Na+ and Ca2+. Thus, their activation would be expected to increase
intracellular Ca2+, directly or indirectly, and potentially contribute to LTP induced by
activity or anoxia.While the activity‐dependent form of LTP is thought to involve the transient
incorporation of GluA2‐lacking CP‐AMPARs (Plant et al. 2006; but see Adesnik & Nicoll, 2007), it is notable that in our OGD model, we found a transient increase in
total GluA2 during the first hour following OGD. Furthermore, the fact that we detected no rapid
change in rectification during the first hour following OGD (see also Quintana
et al. 2006), but only at later
times, contrasts with some earlier studies on acute slices which found an early increase in
rectification after OGD (Dixon et al. 2009; Dias et al. 2013).
These various observations suggest that the different slice preparations used by different groups
might influence the speed of insertion or the synaptic localization of CP‐AMPARs following OGD.
Another critical factor may be the OGD protocol itself. Dixon et al. (2009) performed a 30 min OGD, compared with our 10 min
OGD. Dias et al. (2013) used
10 min OGD but in the presence of 3 mm glucose and at room temperature. All of these
factors (duration of OGD, presence of glucose, and temperature) could influence the speed of
post‐ischaemic AMPAR plasticity and affect neuronal fate after ischaemia.The delayed decrease in total GluA2 we detected in organotypic slices is in keeping
with the general observation that inward rectification of synaptic AMPARs increased. However, it
differs from previous work on cultured hippocampal neurons by Liu et al. (2006) and Fernandes et al. (2014). These two studies found no change in total GluA2
protein abundance at various time points up to 24 h post‐OGD. The fact that we also detected a
downregulation of GluA1 was unexpected, in view of the electrophysiology data showing that EPSCs
were more rectifying at 12 h in WT slices exposed to OGD. The reason for this is unclear, but the
fact that increased targeting of CP‐AMPAR (GluA2‐lacking) subtypes to synaptic sites occurred
following OGD suggests either it also involves other AMPAR subunits, or that even in conditions of
reduced GluA1, sufficient CP‐AMPARs are targeted to synapses to cause a functional change in EPSC
properties.In addition, we calculated the ratio of total GluA1 expression to total GluA2
following acidification of pure HPN cultures. While we found evidence for a decrease in total GluA2
but not in GluA1 following ASIC1a activation, we identified a significant increase in the
GluA1/GluA2 ratio. This increased ratio resembles the relative decrease in GluA2 expression observed
in CA1 following OGD (Pellegrini‐Giampietro et al. 1992). Overall, our study using two different models underlines that ASIC1a
activation by acidosis is necessary and sufficient to induce the increased CP‐AMPAR expression that
is associated with ischaemia and excitotoxicity in vivo (Pellegrini‐Giampietro
et al. 1992; Tanaka
et al. 2002; Noh
et al. 2005).Interestingly, a recent study has demonstrated an opposite role for ASIC1a in the
nucleus accumbens of the ventral striatum. In these neurons, ASIC1a deletion increases CP‐AMPAR
prevalence (Kreple et al. 2014).
ASIC1a‐mediated calcium influx has been shown to induce the Ca2+‐dependent translocation
of the nuclear factor of activated T cells (NFATc) (Li et al. 2013). NFATc promotes GluA2 expression in striatal
neurons (Groth et al. 2008) but
represses it in hippocampal neurons (P. G. Mermelstein, personal communication). Therefore, ASIC1a
could regulate GluA2 expression and CP‐AMPAR prevalence in a tissue specific way through a direct
activation of the NFATc pathway. Based on our observations, ASIC1a could also activate NFATc,
decreasing GluA2 expression in HPNs, by increasing Ca2+‐permeable NMDAR‐ and
VGCC‐mediated currents. Our results highlight the need for further investigation to determine if
ASIC1a may modulate CP‐AMPAR expression in other CNS structures and in diseases that involve both
CP‐AMPARs and ASIC1a channels (such as spinal cord injury and epilepsy) (Weiss, 2011; Wemmie et al. 2013).We also observed that blocking both ASIC1a and CP‐AMPARs appears to be neither
additive nor synergistic, in terms of neuroprotection, as ASIC1a inhibitor suppresses expression of
CP‐AMPARs. This may be useful in refining future combinatorial therapeutic strategies for stroke
(Nakka et al. 2008). The present
findings are consistent with the view that acidosis may contribute to neuronal damage not only as a
result of Ca2+ influx through calcium‐permeable ASIC1a channels (Xiong
et al. 2004; Mari
et al. 2010), but also as result
of delayed expression of GluA2 lacking CP‐AMPARs (Noh et al. 2005). While over‐activation of NMDA receptors has been
shown to contribute to ASIC1a‐dependent damage that occurs during ischaemia (Gao
et al. 2005), the increased
level of protons is itself known to alter markedly a number of other important aspects of synaptic
transmission in divergent ways (Chesler, 2003).
Thus, an increase in protons inhibits NMDAR channel activity by trapping channels in a
non‐conducting state (Traynelis & Cull‐Candy, 1990; Banke et al. 2005). Moreover, mediators of ischaemia, such as arachidonic acid, have been shown to
modulate differentially ASICs and ionotropic glutamate receptors (Miller et al.
1992; Kovalchuk et al. 1994; Allen & Attwell, 2002). Therefore, our results provide an insight into the complex and still
poorly understood interactions between acido‐ and excitotoxicity.In conclusion, we propose that ASIC1a activation can drive certain forms of
CP‐AMPAR plasticity, and that inhibiting ASIC1a affords neuroprotection.
Additional information
Competing interests
The authors declare no competing financial interests.
Author contributions
O.P., P.Q., D.S., M.Z. and S.G.C.‐C. designed the research; P.Q., D.S., O.P. and
M.Z. performed the research and analysed the data; D.M., R.C. and S.K. provided materials and
feedback; and O.P. and S.G.C.‐C. wrote the paper with input from D.S. and M.Z. All authors approved
the final version of the manuscript for publication.
Funding
This work was supported by the EMBO fellowship programme (ALTF 1017–2006 to O.P.),
the Swiss National Science Foundation (PALAB–115678 to O.P., grant 31003A 135735/1 to R.C., grant
31–56852.99 to D.M., grant 3100A0‐105262 to S.K.), Programme Grants from the Medical Research
Council (MR/J002976/1 for S.G.C.‐C. and Mark Farrant), and the Wellcome Trust (086185/Z/08/Z to
S.G.C.‐C. and MF). J.N.W. was supported by the MRC and Wellcome Trust.
Authors: Thorsten Bartsch; Juliane Döhring; Axel Rohr; Olav Jansen; Günther Deuschl Journal: Proc Natl Acad Sci U S A Date: 2011-10-10 Impact factor: 11.205
Authors: John A Wemmie; Jianguo Chen; Candice C Askwith; Alesia M Hruska-Hageman; Margaret P Price; Brian C Nolan; Patrick G Yoder; Ejvis Lamani; Toshinori Hoshi; John H Freeman; Michael J Welsh Journal: Neuron Date: 2002-04-25 Impact factor: 17.173
Authors: Karen L G Farizatto; Sara A McEwan; Vinogran Naidoo; Spyros P Nikas; Vidyanand G Shukla; Michael F Almeida; Aaron Byrd; Heather Romine; David A Karanian; Alexandros Makriyannis; Ben A Bahr Journal: J Mol Neurosci Date: 2017-08-12 Impact factor: 3.444
Authors: Yuanyuan Xu; Yu-Qing Jiang; Ce Li; Mindi He; W George Rusyniak; Naga Annamdevula; Juan Ochoa; Silas J Leavesley; Jiangping Xu; Thomas C Rich; Mike T Lin; Xiang-Ming Zha Journal: FASEB J Date: 2018-02-15 Impact factor: 5.191
Authors: Jan Meyer; Niklas J Gerkau; Karl W Kafitz; Matthias Patting; Fabian Jolmes; Christian Henneberger; Christine R Rose Journal: J Neurosci Date: 2021-12-06 Impact factor: 6.709